SCHEMBL24538005

SCHEMBL24538005

Cc1ccc2nc(NN)cc(Cl)c2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.62
ALDH1A1 P00352 4/20 0.58
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
KDM4E B2RXH2 3/20 0.43
MAPT P10636 2/20 0.43
ACHE P22303 5/20 0.41
BCHE P06276 4/20 0.41
GRIN1 Q05586 4/20 0.41
GRIN2A Q12879 4/20 0.41
PKM P14618 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ELANE P08246 1/20 0.39
RAD52 P43351 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSP90AB1 P08238 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9724148 0.78 LMNA (0.55) LMNAALDH1A1MEN1KMT2AKDM4E
SCHEMBL17827033 0.77 LMNA (0.68) LMNAALDH1A1KDM4EMAPTACHE
SCHEMBL4768081 0.77 LMNA (1.00) LMNAALDH1A1KMT2AKDM4EMAPT
SCHEMBL829490 0.77 LMNA (0.72) LMNAALDH1A1MEN1KMT2AKDM4E
SCHEMBL30572382 0.77 LMNA (1.00) LMNAALDH1A1KMT2AKDM4EMAPT
Hydrochloric Acid SCHEMBL9494656 0.75 LMNA (0.96) LMNAALDH1A1KMT2AKDM4EMAPT
SCHEMBL1592575 0.75 LMNA (0.51) LMNAALDH1A1MEN1KMT2AKDM4E
SCHEMBL19689622 0.74 LMNA (0.68) LMNAALDH1A1MEN1KMT2AKDM4E
SCHEMBL10925980 0.73 LMNA (0.54) LMNAALDH1A1MEN1KMT2AKDM4E
SCHEMBL1592579 0.73 LMNA (0.49) LMNAALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4262986-A1 COMPOUNDS USEFUL AS T CELL ACTIVATORS Gossamer Bio Services, Inc. (US) 2023-10-25 EP disclosed
US-20230271954-A1 COMPOUNDS USEFUL AS T CELL ACTIVATORS GOSSAMER BIO SERVICES INC (US) 2023-08-31 US disclosed
US-20230271954-A1 COMPOUNDS USEFUL AS T CELL ACTIVATORS GOSSAMER BIO SERVICES INC (US) 2023-08-31 US disclosed
US-20230271954-A1 COMPOUNDS USEFUL AS T CELL ACTIVATORS GOSSAMER BIO SERVICES INC (US) 2023-08-31 US disclosed
WO-2022133083-A1 COMPOUNDS USEFUL AS T CELL ACTIVATORS GOSSAMER BIO SERVICES, INC. (US) 2022-06-23 WO disclosed
WO-2022133083-A1 COMPOUNDS USEFUL AS T CELL ACTIVATORS GOSSAMER BIO SERVICES, INC. (US) 2022-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230271954-A1 COMPOUNDS USEFUL AS T CELL ACTIVATORS DGKZ, DGKA, DGKG LMNA 1800/4885ALDH1A1 4626/4885MEN1 3180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.